Acadia Pharmaceuticals (ACAD) Change in Acquisitions & Divestments (2010 - 2026)

Acadia Pharmaceuticals' Change in Acquisitions & Divestments history runs 17 years deep, the most recent figure standing at $86.5 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 33.87% year-over-year to $86.5 million; the TTM figure through Mar 2026 stood at $449.2 million (up 14.23% YoY), while the FY2025 annual figure was $493.5 million, up 50.21% from the prior year.
• Change in Acquisitions & Divestments was $86.5 million for Q1 2026 at Acadia Pharmaceuticals, down from $105.8 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $259.4 million in Q1 2023 to a low of $7.5 million in Q2 2023.
• Historically, Change in Acquisitions & Divestments has averaged $104.4 million across 5 years, with a median of $103.8 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Change in Acquisitions & Divestments slumped 89.22% in 2023, then surged 986.67% in 2024.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $75.8 million in 2022, then soared by 36.89% to $103.8 million in 2023, then gained by 7.8% to $111.8 million in 2024, then slipped by 5.45% to $105.8 million in 2025, then dropped by 18.2% to $86.5 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $86.5 million (Q1 2026), $105.8 million (Q4 2025), and $125.6 million (Q3 2025), per Business Quant data.